Oct 17 (Reuters) - Immunovia AB (publ) IMMNOV.ST :
* IMMUNOVIA LAUNCHES A STRATEGIC PARTNERSHIP WITH
PROTEOMEDIX TO
LEVERAGE RESEARCH AND DEVELOPMENT EFFORTS WITH INCREASED FOCUS
ON COMMERCIALIZATION
* ENTERS INTO A STRATEGIC PARTNERSHIP WITH PROTEOMEDIX TO
LEVERAGE
ITS SUBSTANTIAL JOINT DEVELOPMENT EXPERIENCE IN DIAGNOSTIC
TECHNOLOGIES FOR DETECTION OF CANCER
* THIS WILL ENABLE INCREASED RESEARCH AND DEVELOPMENT
PRODUCTIVITY
FOR IMMUNOVIA AS COMPANY CONTINUES TO STRENGTHEN ITS COMMERCIAL
DEVELOPMENT IN US.
Source text for Eikon: ID:nWkrWlbkt
Further company coverage: IMMNOV.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))